Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psychiatric Disorders
SoPsy-SoSad
1 other identifier
observational
1,000
1 country
1
Brief Summary
Despite international efforts to identify biomarkers of depression, none has been transferred to clinical practice, neither for diagnosis, evolution, nor therapeutic response. This led us to build a French national cohort (through the clinical and research network named SoPsy within the French biological psychiatry society (AFPBN) and sleep society (SFRMS)), to better identify markers of sleep and biological rhythms and validate more homogeneous subgroups of patients, but also to specify the manifestations and pathogeneses of depressive disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2033
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2033
May 16, 2024
May 1, 2024
10 years
January 12, 2023
May 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
amount of REM sleep
during the polysomnography, amount of REM sleep (in minutes)
at inclusion
Secondary Outcomes (25)
duration of the first stage of REM sleep
at inclusion
duration of the first episode of N3
at inclusion
latency of the first episode of N3
at inclusion
duration of N1 slow-wave sleep
at inclusion
duration of N2 slow-wave sleep
at inclusion
- +20 more secondary outcomes
Eligibility Criteria
The entry point for the cohort is any patient with a major depressive episode, in order to integrate the maximum variance in terms of manifestations, and thus to be able to contrast the different clinical pictures according to the biomarkers of sleep and biological rhythms. The aim of this cohort is to pool the efforts of this network and to homogenise the assessments, in order to characterise more precisely and in a standardised manner the alterations in sleep and rhythms in depressive disorders, according to the different subtypes of disorder.
You may qualify if:
- Individuals with depressive episode characterized according to the DSM-5 criteria regardless of the associated characteristics and comorbidities.
- Adult and child
- Affiliated to a social security
You may not qualify if:
- don't understand or read french
- Medical condition incompatible with administration of questionnaire
- impossibility to give informed decision (subject in an emergency condition, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Bichat Claude Bernard
Paris, 75018, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2023
First Posted
May 19, 2023
Study Start
February 1, 2023
Primary Completion (Estimated)
February 1, 2033
Study Completion (Estimated)
May 1, 2033
Last Updated
May 16, 2024
Record last verified: 2024-05